在血液学疾病中的异构干细胞移植:十年的经验
Salman Arif1, Natasha Ali2, Usman Shaikh2
1Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan.
International journal of hematology-oncology and stem cell research
|December 20, 2024
概括
全基性造血细胞移植 (allo-HCT) 为血液疾病提供治疗潜力. 这项研究突出了GVHD和败血症等关键结果和并发症,强调需要优化护理以提高生存率.
科学领域:
- 血液学 血液学 血液学
- 移植医学 移植医学
- 免疫学 免疫学 免疫学
背景情况:
- 全基血造细胞移植 (allo-HCT) 是血液学疾病的关键治疗选择.
- 管理并发症对于成功的alo-HCT结果至关重要.
研究的目的:
- 为了评估血液病中的allo-HCT结果.
- 在单一中心环境中识别显著的并发症和风险因素.
主要方法:
- 对接受allo-HCT (2011-2021) 的180名患者进行了回顾性分析.
- 评价的指示,生存,植入,复发,GVHD,和TRM. 的评估.
主要成果:
- 无形性贫血和严重的thalassemia是常见的迹象.
- 急性GVHD发生在30%;败血症是非复发性死亡的主要原因.
- 总生存率为62%,无病生存率为79%.
结论:
- -HCT为血液学疾病提供了有价值的治疗方法.
- 解决GVHD和感染对于改善患者存活率至关重要.
- 需要进一步优化移植技术,以尽量减少并发症.
更多相关视频
05:32In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
Published on: February 16, 2024
386
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.5K
相关概念视频
Bone Marrow Sampling and Transplants
282
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
282
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Tissue Transplantation
338
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
338
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
